2,157
Participants
Start Date
July 31, 2012
Primary Completion Date
November 30, 2015
Study Completion Date
March 31, 2016
Ularitide
Placebo
Ciudad Autonoma
La Plata
Rosario
San Miguel de Tucumán
Basel
Debrecen
Córdoba
San Vicente
Córdoba
Lugano
Zurich
Kortrijk
Aalst
Tallinn
Berlin
The Bronx
Belgrade
Belgrade
Belgrade
Zemun
Brooklyn
Berlin
Safed
Berlin
Tallinn
Alessandria
Santiago de Compostela
Genova
Greifswald
Niš
Niška Banja
Philadelphia
Legnano
Rozzano
Milan
Milan
Washington D.C.
Varese
Kamenitz
San Fermo della Battaglia
Como
Charlottesville
Midlothian
Norfolk
Salem
Besançon
Eskişehir
Madrid
Novara
Majadahonda
Aranjuez
Majadahonda
Charleston
Lawrenceville
Toulouse
Jacksonville
Istanbul
Huntsville
Montgomery
Nashville
Chattanooga
Hadera
Bologna
Kocaeli
Columbus
Toledo
Bochum
Middletown
Kaunas
Cincinnati
Royal Oak
Detroit
Detroit
Detroit
Kaunas
Hradec Králové
Minneapolis
Sivas
Rockford
Bad Nauheim
Peoria
St Louis
Langen
Bayonne
Groß-Umstadt
Brno
Kansas City
Lincoln
Bron
Bari
Alexandria
Frýdek-Místek
Dallas
Paris
Fort Worth
Houston
Austin
Littleton
Napoli
Poitiers
Nuremberg
Sacramento
Erfurt
Oradea
Iași
Nazareth
Afula
Nahariya
Kfar Saba
Holon
Ashkelon
Trumbull
Worcester
Newark
Coronel Suárez
Córdoba
Corrientes
Córdoba
Córdoba
Córdoba
San Miguel de Tucumán
Santa Fe
Santa Fe
Goiânia
Porto Alegre
Campinas
São José do Rio Preto
São Paulo
Halifax
Montreal
Montreal
Brno
Olomouc
Prague
Prague
Prague
Prague
Prague
Znojmo
Espoo
Jena
Roma
Riga
Vilnius
Beverwijk
Ede
Gorinchem
Groningen
Leiderdorp
Sneek
Krakow
Krakow
Lodz
Warsaw
Warsaw
Wroclaw
Bucharest
Bucharest
L'Hospitalet de Llobregat
Sant Joan Despí
Alicante
Barcelona
Barcelona
Lead Sponsor
Quintiles, Inc.
INDUSTRY
Cardiorentis
INDUSTRY